Research ExplorerPublicationsReply to letter that comments on 'Intraventricular methotrex...

Reply to letter that comments on 'Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma

Standard

Reply to letter that comments on 'Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma : Feasibility, acute toxicity and evidence for efficacy'. / Pompe, R S; von Bueren, A O; Mynarek, M; von Hoff, K; Rutkowski, S.

In: EUR J CANCER, Vol. 56, 03.2016, p. 181-2.

Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

Harvard

Pompe, RS, von Bueren, AO, Mynarek, M, von Hoff, K & Rutkowski, S 2016, 'Reply to letter that comments on 'Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy'', EUR J CANCER, vol. 56, pp. 181-2. https://doi.org/10.1016/j.ejca.2015.11.011

APA

Pompe, R. S., von Bueren, A. O., Mynarek, M., von Hoff, K., & Rutkowski, S. (2016). Reply to letter that comments on 'Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy'. EUR J CANCER, 56, 181-2. https://doi.org/10.1016/j.ejca.2015.11.011

Vancouver

Pompe RS, von Bueren AO, Mynarek M, von Hoff K, Rutkowski S. Reply to letter that comments on 'Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy'. EUR J CANCER. 2016 Mar;56:181-2. https://doi.org/10.1016/j.ejca.2015.11.011

Bibtex

@article{650548e424234ee1adb324bcbe01699b,
title = "Reply to letter that comments on 'Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy'",
author = "Pompe, {R S} and {von Bueren}, {A O} and M Mynarek and {von Hoff}, K and S Rutkowski",
year = "2016",
month = mar,
doi = "10.1016/j.ejca.2015.11.011",
language = "English",
volume = "56",
pages = "181--2",
journal = "EUR J CANCER",
issn = "0959-8049",
publisher = "Elsevier Limited",

}

RIS

TY - JOUR

T1 - Reply to letter that comments on 'Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma

T2 - Feasibility, acute toxicity and evidence for efficacy'

AU - Pompe, R S

AU - von Bueren, A O

AU - Mynarek, M

AU - von Hoff, K

AU - Rutkowski, S

PY - 2016/3

Y1 - 2016/3

U2 - 10.1016/j.ejca.2015.11.011

DO - 10.1016/j.ejca.2015.11.011

M3 - Other (editorial matter etc.)

C2 - 26774521

VL - 56

SP - 181

EP - 182

JO - EUR J CANCER

JF - EUR J CANCER

SN - 0959-8049

ER -